Corcept Therapeutics Shares Are Trading Higher After Truist Securities Reiterated a Buy Rating on the Stock and Raised Its Price Target From $44 to $65.
Corcept Therapeutics Shares Are Trading Higher After Truist Securities Reiterated a Buy Rating on the Stock and Raised Its Price Target From $44 to $65.
corcept醫療股票上漲，因為Truist Securities重申買入評級並將股票目標價從44美元提高至65美元。
Corcept Therapeutics Shares Are Trading Higher After Truist Securities Reiterated a Buy Rating on the Stock and Raised Its Price Target From $44 to $65.
Corcept醫療股票上漲，在Truist證券重申買入評級並將目標價格從44美元升至65美元后。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。